Summary
People are risking their health by obtaining Retatrutide, a weight-loss drug not yet approved by the FDA, through the gray market. This trend is driven by individuals seeking alternatives to approved drugs like Ozempic, despite warnings from medical professionals about the unknown risks.
Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.
Pick a story, apply your brand template, and publish polished graphics to Facebook, Instagram, LinkedIn, and more — without opening a design tool.
Create Image PostDescribe the story, headline, colors, and style you want.
Try Prompt to PostCombine branded news graphics with narration — from your audio library, a live recording, or AI text-to-speech — and share as engaging short-form content.
Create Audio PostUpload your footage, apply a video template with baked-in headlines, add optional audio, and schedule posts across every connected social channel.
Create Video PostCombine several news items into a single swipeable carousel post — with a shared title, unified caption, and per-slide template content for maximum engagement.
Create CarouselUpload your media, craft the perfect caption with AI assistance, preview on every platform, and schedule posts for the exact moment your audience is online.
Schedule a PostTransform breaking news into long-form, SEO-optimized blog posts with AI writing, a rich text editor, featured images, and one-click social image post creation.
Create Blog PostTurn any news article into a professional anchor video with AI-generated presenters, natural voice narration, and lip-sync animation — no studio, no crew, no wait.
Learn moreAbout the public HyperFast News news feed powered by NewsEngine.
Purpose-built AI tools and business automation workflows for publishers, stores, agencies, and brands.
Products
© 2026 HyperFast. All Rights Reserved.
An initiative of Xzect Labs Private Limited
Studies Show Lower Doses of Weight Loss Drugs Match High-Strength Efficacy, Saving Patients £1000
15 Sept 2026, 6:15 am · News
Middle-Class Dealers Illegally Selling Unlicensed 'Godzilla' Fat Jabs from China
15 Sept 2026, 6:15 am · News
Weight Loss Drugs: Can Surging Demand Be Managed?
15 Sept 2026, 6:15 am · News
More Than 60 Deaths in Australia Linked to Weight Loss Drugs
15 Sept 2026, 6:15 am · News
Over 150 Deaths Reported After Weight Loss Drug Use, GLP-1 Side Effects Noted
15 Sept 2026, 6:15 am · News
Study Links Weight Loss Drugs Like Ozempic and Wegovy to Hair Loss
15 Sept 2026, 6:15 am · News
